Medicine, Health & Food
Volume: 132 , Issue: 1 , September Published Date: 11 September 2023
Publisher Name: IJRP
Views: 277 , Download: 224 , Pages: 106 - 110
DOI: 10.47119/IJRP1001321920235443
Publisher Name: IJRP
Views: 277 , Download: 224 , Pages: 106 - 110
DOI: 10.47119/IJRP1001321920235443
Authors
# | Author Name |
---|---|
1 | Syahrul Ramadan Rambe |
2 | Reza Mahruzza Putra |
3 | Heru Rahmadhany |
Abstract
Tuberculous Spondylitisis a secondary infectious disease of the spine that often occurs, from some literature it is found that almost half of all scletal tuberculosis sufferers are Tuberculous Spondylitis. Until now, the management of Tuberculous Spondylitis is still controversial due to the high clinical variation of Tuberculous Spondylitis. The Medical Research Council of the United Kingdom (MRC, London) recommends using a 6-month regimen of isoniazid and rifampicin as standard therapy for tuberculous spondylitis, but this study did not include patients with three or more spinal cord injuries. This study aims to assess the clinical outcome of the posterior spinal fusion technique on the degree of kyphosis, neurological deficits and vertebral body fusion in tuberculous spondylitis patients. This type of research is an observational analytic, cross-sectional approach to analyze the effect of the posterior spinal fusion technique on the degree of kyphosis and neurological deficits in tuberculous spondylitis patients before and after intervention. Overall, in this study there were significant clinical outcome differences in tuberculous spondylitis patients who underwent posterior spinal fusion techniques with a p value <0.05, except for vertebrae corpus fusion 1 month postoperatively, there were no significant differences between preoperative and postoperatively. posterior spinal fusion with p value = 1.000 (p > 0.05) and there was no relationship between loss of correction and vertebral body fusion 1 month postoperatively tested with Pearson statistics where p = 0.451.Tuberculous Spondylitisis a secondary infectious disease of the spine that often occurs, from some literature it is found that almost half of all scletal tuberculosis sufferers are Tuberculous Spondylitis. Until now, the management of Tuberculous Spondylitis is still controversial due to the high clinical variation of Tuberculous Spondylitis. The Medical Research Council of the United Kingdom (MRC, London) recommends using a 6-month regimen of isoniazid and rifampicin as standard therapy for tuberculous spondylitis, but this study did not include patients with three or more spinal cord injuries. This study aims to assess the clinical outcome of the posterior spinal fusion technique on the degree of kyphosis, neurological deficits and vertebral body fusion in tuberculous spondylitis patients. This type of research is an observational analytic, cross-sectional approach to analyze the effect of the posterior spinal fusion technique on the degree of kyphosis and neurological deficits in tuberculous spondylitis patients before and after intervention. Overall, in this study there were significant clinical outcome differences in tuberculous spondylitis patients who underwent posterior spinal fusion techniques with a p value <0.05, except for vertebrae corpus fusion 1 month postoperatively, there were no significant differences between preoperative and postoperatively. posterior spinal fusion with p value = 1.000 (p > 0.05) and there was no relationship between loss of correction and vertebral body fusion 1 month postoperatively tested with Pearson statistics where p = 0.451.